-

Asahi Kasei Medical to Build New Assembly Plant for Planova™ Filters

original Planova™ Virus Removal Filters (Photo: Business Wire)

Planova™ Virus Removal Filters (Photo: Business Wire)

TOKYO--(BUSINESS WIRE)--Asahi Kasei Medical has decided to expand the production capacity of Planova™ filters by constructing a new assembly plant in Nobeoka, Miyazaki, Japan. The new plant will be designed to realize a smart factory by accelerating manufacturing automation and digital transformation in order to enhance quality and production efficiency. The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024.

The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market and increased the urgent demand for Planova™ filters, which are indispensable to develop and commercially produce new drugs in pharmaceutical companies. Asahi Kasei Medical has been making significant milestones in expanding production capacity to meet such demands. This new assembly plant follows the investment announced in 2021 for the expansion of the spinning plant for Planova™ BioEX in Oita, Japan. As for the Planova™ N series filter, all six existing plants, including the spinning plant completed in 2019 in Miyazaki, Japan, have been operating efficiently to meet the increasing demand worldwide.

Asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. Asahi Kasei Medical aims to provide "Assurance Beyond Expectation" in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support, and biosafety testing services to help biologics manufacturers safely and efficiently produce medicines that patients can trust.

Asahi Kasei Medical will continue to reinforce its global supply infrastructure for Planova™ through proactive investments in manufacturing facilities in order to support the early provision of vaccines and life-saving therapies to as many people as possible.

Contacts

For more information, please contact:
Shizuka Nawa
Corporate Communications
Asahi Kasei Corp.
Phone: +81-(0)3-6699-3008

Industry:

Asahi Kasei Corp.

TOKYO:3407
Release Summary
Asahi Kasei Medical has decided to expand the production capacity of Planova™ filters by constructing a new assembly plant.
Release Versions
EnglishChinese Simplified

Contacts

For more information, please contact:
Shizuka Nawa
Corporate Communications
Asahi Kasei Corp.
Phone: +81-(0)3-6699-3008

Social Media Profiles
Asahi Kasei
More News From Asahi Kasei Corp.

Asahi Kasei Successfully Demonstrates Biomethane Production with High Yield and High Purity Using Biogas from Organic Waste

TOKYO & NOVI, Mich. & DÜSSELDORF, Germany--(BUSINESS WIRE)--Diversified global manufacturer Asahi Kasei has successfully completed a demonstration trial of an innovative biogas purification system using zeolites in Kurashiki, Okayama Prefecture, Japan. Begun in February 2025, the trial achieved biomethane production with yield of up to 99.5% or more and purity of 97% or more. With such exceptional performance in both yield and purity, the system holds promise for the cost-effective production a...

Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company

TOKYO & NEW YORK & DÜSSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei Corp. (TOKYO:3407) today announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei (“the Acquisition”) through a voluntary tender offer for Calliditas (“the Tender Offer”). The Tender Offer will also include a concurrent offer by Asahi Kasei to acquire all American Depos...

Dr. Akira Yoshino Chosen for the Grand Prize of the VinFuture Prize

TOKYO & HANOI, Vietnam--(BUSINESS WIRE)--Asahi Kasei Honorary Fellow Dr. Akira Yoshino has been chosen for the Grand Prize of the 2023 VinFuture Prize in recognition of his contributions to the invention of lithium-ion battery (LIB). Dr. Yoshino invented a completely new combination of carbon for the negative electrode and LiCoO2 (lithium cobalt oxide) for the positive electrode, developed the fundamental technology for the LIB which uses aluminum as positive current collector material, and fab...
Back to Newsroom